[1]
NM Al-Khero, K. and خالد 2025. Effect of tyrosine kinase inhibitor in patients with chronic myeloid leukemia (cytogenetic, molecular response) in Mosul. Annals of the College of Medicine, Mosul. 40, 2 (Jun. 2025), 1–8. DOI:https://doi.org/10.33899/mmed.2018.160000.